Dividend Aristocrats are companies that have consistently increased their dividend payments for at least 25 consecutive years.
Keep Reading →
February 24 - Dividend Stocks, Hedge Funds, News
Dividend investing is often regarded as a strategy that rewards patience, as it tends to generate stronger returns over the long term.
Keep Reading →
February 24 - Dividend Stocks, Hedge Funds, News
Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for medicines in China.
Keep Reading →
February 16 - Hedge Funds, Industries, News
Lee Munder Capital Group Investments, more commonly known as LMCG Investments, LLC, is an independent, employee-owned investment management company.
Keep Reading →
February 13 - Hedge Funds, News
Jim Cramer, the host of Mad Money, on Tuesday, took a close look at President Donald Trump’s recent actions and his effect on the stock market, urging investors to pay closer...
Keep Reading →
February 5 - Hedge Funds, News
Cancer is the second leading cause of death across the globe, second to cardiovascular disease.
Keep Reading →
February 2 - Hedge Funds, News
Operator: Good morning and thank you for standing by. Welcome to the AbbVie Fourth Quarter 2024 Earnings Conference Call.
Keep Reading →
February 1 - News, Transcripts
AbbVie (ABBV), a large drug maker, is jumping 8% after the company provided significantly higher-than-expected 2025 earnings per share guidance this morning.
Keep Reading →
January 31 - Market Movers, News
On December 12, Tom Lee, Fundstrat Global Advisors managing partner and head of research, appeared on CNBC to talk about his 2025 playbook.
Keep Reading →
January 28 - Hedge Funds, News
As of January 2025, the prevailing sentiment among US economic experts leans towards cautious optimism regarding the stock market's trajectory.
Keep Reading →
January 24 - Hedge Funds, News
Halal stocks are shares in companies that adhere to Shariah law.
Keep Reading →
January 22 - Dividend Stocks, Hedge Funds, News
The market outlook is as uncertain as it gets.
Keep Reading →
January 21 - Hedge Funds, News
Dividend stocks, while popular among investors, have been underperforming for a while.
Keep Reading →
January 21 - Dividend Stocks, Hedge Funds, News
We came across a bullish thesis on AbbVie Inc. (ABBV) on Disruptive analytics’ Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on ABBV.
Keep Reading →
January 20 - News, Stock Analysis
Louis Navellier is a prominent American investor, author, and financial analyst, best known for his quantitative approach to stock selection and his long-standing track record...
Keep Reading →
January 18 - Hedge Funds, News
Investing in dividend stocks has been a focal point for investors for several years. The attractive income generated from these stocks motivates many to invest.
Keep Reading →
January 13 - Dividend Stocks, Hedge Funds, News
Macroeconomic factors have weighed on US stocks in the final days of the year, with the broader market declining by over 1% in the past week.
Keep Reading →
December 30 - Dividend Stocks, Hedge Funds, News
The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower deal values, reflecting a shift toward smaller, more strategic transactions...
Keep Reading →
December 30 - Dividend Stocks, Hedge Funds, News
To select stocks with long-term growth potential, investors should focus on fundamental analysis, evaluating financial health through earnings history, revenue growth, and profit...
Keep Reading →
December 30 - Hedge Funds, News
Dividend stocks had a challenging year in 2024 as investor interest largely shifted toward technology stocks.
Keep Reading →
December 29 - Dividend Stocks, Hedge Funds, News
Polaris Capital Management, an investment management company, released its third quarter 2024 investor letter. A copy of the same can be downloaded here.
Keep Reading →
December 23 - Hedge Fund Investor Letters, News
On December 12, Tom Lee, Fundstrat Global Advisors managing partner and head of research, joined CNBC's 'Closing Bell' to discuss his playbook for 2025.
Keep Reading →
December 22 - Hedge Funds, News
Generating income has consistently been a primary goal for investors. To achieve this, they often opt for investments that provide steady and reliable returns over time.
Keep Reading →
December 20 - Dividend Stocks, Hedge Funds, News
As investors near retirement, achieving financial stability becomes a top priority.
Keep Reading →
December 17 - Dividend Stocks, Hedge Funds, News
Statistically, November and December tend to be great months for stocks.
Keep Reading →
December 11 - Hedge Funds, News
In the face of economic uncertainty, consumer preferences in the beauty industry are changing.
Keep Reading →
December 10 - Hedge Funds, Industries, News
Dividend Kings are a distinguished group of companies that have achieved at least 50 consecutive years of dividend increases.
Keep Reading →
December 3 - Dividend Stocks, Hedge Funds, News
Healthcare, which includes numerous businesses that offer patient care, conduct research and development of novel treatments, and design, produce, and distribute diagnostic tools...
Keep Reading →
November 29 - Hedge Funds, News
A decade ago, the cannabis industry was in full swing as stock valuations exploded to record highs in states across the country legalizing pot use for medicinal and recreational...
Keep Reading →
November 27 - Hedge Funds, News
Investors usually buy stocks with the expectation that their value will increase as the company grows more profitable. However, stocks can offer additional advantages.
Keep Reading →
November 25 - Dividend Stocks, Hedge Funds, News
The healthcare sector depends on medical technology advancements, particularly devices used in disease prevention, diagnosis, and treatment.
Keep Reading →
November 21 - News, Stock Analysis
AbbVie stock fell 10% after emraclidine, its drug for schizophrenia, failed during the final stages of its trials.
Keep Reading →
November 16 - News, Stock Analysis
Healthcare takes the concept of 'defensive' further than almost any industry, encompassing many companies that provide patient care, engage in the research and development of ...
Keep Reading →
November 4 - Hedge Funds, Industries, News
Operator: Good morning, and thank you for standing by. Welcome to the AbbVie Third Quarter 2024 Earnings Conference Call.
Keep Reading →
October 31 - News, Transcripts
On Tuesday, Jim Cramer, host of Mad Money, shared his thoughts on the market's recent volatility and offered advice to investors regarding earnings reports.
Keep Reading →
October 17 - Hedge Funds, News
The medical and healthcare industry is one of the largest globally, with a steady demand for products and services due to the biological nature of humans.
Keep Reading →
October 15 - News
As the fourth quarter of 2024 starts, the market is once again back to debating about the Federal Reserve's interest rate cuts.
Keep Reading →
October 8 - News
PGIM Jennison Health Sciences Fund released its second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
October 3 - Hedge Fund Investor Letters, News
The recent market surge has raised concerns about potential market overvaluation.
Keep Reading →
September 27 - Hedge Funds, News
In a recent episode of Mad Money, Jim Cramer discussed how the slowing economy might lead the Federal Reserve to ease its policies.
Keep Reading →
September 16 - Hedge Funds, News
In early April 2024, Goldman Sachs Inc.’s data revealed that short selling on individual US-listed stocks was at the highest level in 6 months, and the most targeted sectors...
Keep Reading →
September 3 - Hedge Funds, News
In 2022, the global oncology market was valued at approximately $203.42 billion and is expected to reach over $470.61 billion by 2032, growing at a compound annual growth rate...
Keep Reading →
August 31 - Hedge Funds, Industries, News
The U.S. stock market has been on a roll, with major indices clocking double-digit gains even with the U.S. economy showing signs of weakness.
Keep Reading →
August 30 - Hedge Funds, News
Operator: Good morning and thank you for standing by. Welcome to the AbbVie Second Quarter 2024 Earnings Conference Call.
Keep Reading →
July 26 - News, Transcripts
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” second quarter 2024 investor letter.
Keep Reading →
July 22 - Hedge Fund Investor Letters, News
The United States holds the title of the largest economy in the world, according to the IMF in 2024 the United States had a GDP of approximately $28.78 trillion, a GDP per capita...
Keep Reading →
June 19 - Business, Industries, News
The age-old debate of investing in dividend growth or high-yield stocks continues to reappear within the dividend investing realm.
Keep Reading →
June 6 - Dividend Stocks, Hedge Funds, News
Dividend growth investing strategy is in the spotlight these days as investors scramble to offset market risks in a higher-for-longer environment where interest rates aren’t...
Keep Reading →
May 26 - Hedge Funds, News
In this article, we discuss 15 best S&P 500 dividend stocks to buy now.
Keep Reading →
May 7 - Dividend Stocks, Hedge Funds, News
In this piece, we will take a look at the top 25 stocks in the S&P 500 by index weight right now.
Keep Reading →
May 2 - News, Quantitative Investing